Carmen Andrada Mirea

Dr. Carmen Andrada Mirea

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
Cristina PopescuCristina Popescu
Cristina Popescu
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Beatrice Bălăceanu-GurăuBeatrice Bălăceanu-Gurău
Beatrice Bălăceanu-Gurău
CMCarmen Andrada Mirea
Carmen Andrada Mirea
ARAndreea Racoviță
Andreea Racoviță
Mara MihaiMara Mihai
Mara Mihai
Ultrasonography is a well-tolerated procedure that aids in the targeted esthetic therapies of special cutaneous regions, as well as in the prevention (vascular mapping, identification of previous filler, and others) and management of potential complications (vascular occlusion, external vascular compression, product misplacement or migration, inflammatory reactions, and others). It has lately been promoted as the first-line imaging tool to address injectables. In this article, we aim to review the evolving role of ultrasonography in cosmetic filler procedures, from the fundamental ultrasound characterization of cosmetic fillers to the ultrasound-enhanced detection and management of cosmetic filler complications, including ultrasound’s role in hyaluronidase-guided injections for cosmetic filler dissolution. Furthermore, the paper explores the integral role played by ultrasound in enhancing the precision, efficacy, and safety of additional minimally invasive aesthetic techniques such as mesotherapy, radiofrequency, cryolipolysis, and polydioxanone procedures.

25 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Cristina PopescuCristina Popescu
Cristina Popescu
CMCarmen Andrada Mirea
Carmen Andrada Mirea
ATAndreea Mihaela Truica
Andreea Mihaela Truica
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
APAndrei-Ludovic Porosnicu
Andrei-Ludovic Porosnicu
Marius Nicolae PopescuMarius Nicolae Popescu
Marius Nicolae Popescu
Background: High-frequency ultrasound (HFUS) represents a valuable non-invasive imaging modality for assessing cutaneous tumors. In basal cell carcinoma (BCC), preoperative estimation of tumor depth may support therapeutic decision-making and surgical planning. However, agreement between HFUS-derived and histopathologic depth measurements remains incompletely characterized, particularly with 20 MHz probes in routine clinical practice. Objectives: To evaluate agreement between 20 MHz HFUS and histopathology for BCC tumor depth using Bland–Altman analysis and to derive a preliminary correction equation to estimate histologic depth from HFUS measurements. Methods: This prospective observational pilot study included 15 patients with 16 histologically confirmed BCC lesions. All lesions underwent preoperative 20 MHz HFUS followed by surgical excision, with HFUS-derived tumor depth compared with histopathologic depth. Agreement was assessed using Bland–Altman analysis, and linear regression was performed to derive a preliminary correction equation. Results: Sixteen BCC lesions were analyzed. The mean difference between HFUS and histopathologic tumor depth was −0.07 mm, with 95% limits of agreement from −1.58 to +1.45 mm. HFUS and histopathologic depth measurements were highly correlated (R2 = 0.99). A correction equation was derived: estimated histopathologic depth (mm) = −0.52 + 1.10 × HFUS depth (mm). Conclusions: Twenty MHz HFUS demonstrated good agreement with histopathology for tumor depth assessment in BCC, with clinically acceptable variability. The proposed correction equation may improve interpretation of HFUS measurements; however, further validation in larger cohorts is required.

2 February 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
CMCarmen Andrada Mirea
Carmen Andrada Mirea
Cristina PopescuCristina Popescu
Cristina Popescu
TTTiberiu Tebeică
Tiberiu Tebeică
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Background/Objectives: Prurigo pigmentosa (PP) is a rare inflammatory dermatosis characterized by recurrent pruritic eruptions resolving with reticulated hyperpigmentation. Initially described in young Asian women, PP is increasingly reported worldwide, often linked to ketosis-inducing factors such as low-carbohydrate diets. This report documents the first case of PP in a Romanian patient and highlights the importance of recognizing the condition in diverse populations. Methods: We describe a 16-year-old girl with a six-month history of pruritic eruptions on the neck, trunk, shoulders, and thighs. A detailed clinical assessment was conducted, including dietary history, physical examination, laboratory evaluation of urinary ketones, and skin biopsy for histopathological analysis. Results: Clinical examination revealed erythematous papules and plaques with peripheral pustules and post-inflammatory hyperpigmentation. Substantial weight loss and elevated urinary ketone levels suggested dietary-induced ketosis from a strict low-carbohydrate diet. Histopathological findings confirmed the diagnosis of PP. The patient’s skin lesions resolved following carbohydrate reintroduction and doxycycline therapy. Conclusions: This case highlights the association between ketosis and PP, emphasizing the importance of thorough dietary history-taking and histopathological confirmation for accurate diagnosis. As ketogenic diets become more popular globally, heightened awareness of PP is essential to ensure timely diagnosis and effective management.

1 November 2024 in Medicina
Verified
Journal Article
Open access
PDF file
CMCarmen Andrada Mirea
Carmen Andrada Mirea
Cristina PopescuCristina Popescu
Cristina Popescu
ARAndreea Racoviță
Andreea Racoviță
COCristina-Mihaela Olaru
Cristina-Mihaela Olaru
ITIrina Tudose
Irina Tudose
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
Cutaneous metastases from clear cell renal carcinoma (ccRC) are uncommon and often indicate a poor prognosis. These metastases typically occur on the scalp, face, and trunk, and they can be difficult to diagnose due to their resemblance to benign dermatological tumors. We report the case of a 56-year-old patient with a history of ccRC (TNM stage 4) who was referred to our dermatology department with two rapidly enlarging, painful lesions on the left jawline and scalp, which had developed one month and one week earlier, respectively. On examination, the lesions appeared as well-defined, round to oval plaques with a central ulceration and a peripheral red rim, suggestive of an inflammatory appearance. Dermoscopic examination revealed a structureless pink to orange pattern, atypical central vessels, and irregular linear vessels in a corona-like arrangement. Despite the patient’s stable oncological treatment for six months, pain management had recently included paracetamol, tramadol, and NSAIDs. The primary presumptive diagnosis was of cutaneous metastasis, considering the patient’s history of metastatic ccRC. However, given the recent initiation of new pharmacological agents, the rapid progression of the cutaneous lesions, and their clinical presentation, alternative differential diagnoses were considered, including drug-induced reactions such as erythema multiforme or fixed drug eruption. A biopsy of the facial lesion revealed immunohistochemical positivity for CD10, CAIX, and PAX8, confirming the diagnosis of metastatic ccRC with sarcomatoid differentiation. Unfortunately, despite continued targeted therapies and palliative care, the patient’s condition deteriorated rapidly, leading to death two months later. This case highlights the potential for extremely rapidly evolving cutaneous metastases from ccRC and their capacity to occasionally mimic atypical drug eruptions. Additionally, it reaffirms the poor prognosis of such metastases, as evidenced by the patient’s death within two months.

14 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CMCarmen Andrada Mirea
Carmen Andrada Mirea
Cristina PopescuCristina Popescu
Cristina Popescu
ARAndreea Racoviță
Andreea Racoviță
Liliana Gabriela PopaLiliana Gabriela Popa
Liliana Gabriela Popa
ITIrina Tudose
Irina Tudose
LPLiliana Gabriela Popa
Liliana Gabriela Popa
Cutaneous metastases from clear cell renal carcinoma (ccRC) are uncommon and often indicate a poor prognosis. These metastases typically occur on the scalp, face, and trunk, and they can be difficult to diagnose due to their resemblance to benign dermatological tumors. We report the case of a 56-year-old patient with a history of ccRC (TNM stage 4) who was referred to our Dermatology department with two rapidly enlarging, painful lesions on the left jawline and scalp, which had developed one month and one week earlier, respectively. On examination, the lesions appeared as well-defined, round to oval plaques with a central ulceration and a peripheral red rim. Dermoscopic examination revealed a structureless pink to orange pattern, atypical central vessels, and irregular linear vessels in a corona-like arrangement. Despite the patient's stable oncological treatment for six months, pain management had recently included paracetamol, tramadol, and NSAIDs. Given the recent medication changes and the clinical presentation, differential diagnoses initially included drug-induced eruptions such as erythema multiforme or fixed drug eruption. However, a biopsy of the facial lesion revealed immunohistochemical positivity for CD10, CAIX, and PAX8, confirming the diagnosis of metastatic ccRC with sarcomatoid differentiation. Unfortunately, despite continued targeted therapies and palliative care, the patient’s condition deteriorated rapidly, leading to death two months later. This case highlights the aggressive progression and poor prognosis associated with cutaneous metastases from renal cell carcinoma, particularly once the skin is involved.